Rhodiola Rosea P.E. Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Rhodiola Rosea P.E. Market Size
The global Rhodiola Rosea P.E. market was valued at US$ 34 million in 2023 and is anticipated to reach US$ 38 million by 2030, witnessing a CAGR of 1.7% during the forecast period 2024-2030.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-34U400/Global_Rhodiola_Rosea_P_E_Market_Insights_and_Forecast_to_2028

Rhodiola Rosea P.E. Market
Rhodiola rosea (commonly golden root, rose root, roseroot, western roseroot, Aaron's rod, Arctic root, king's crown, lignum rhodium, orpin rose) is a perennial flowering plant in the family Crassulaceae.
Rhodiola rosea P.E. is derived from the root and rhizome of Rhodiola rosea. It has been traditionally used as a rare Chinese medicinal herb, and it has also been applied in Tibetan medicine.
Since the 1970s, the natural stocks of rhodiola rosea are continuously diminishing as a result of unregulated collection. According to the Red List, the plant is severely endangered and even threatened by extinction. Rhodiola rosea has been on the list of the rare plants of Siberia since 1980 and the plant needs government protection.
In the face of declining availability of the natural supply, rhodiola rosea P.E. will continue in the state that production behind demand. And the price will continue to rise for some time.
At present, the major manufacturers of rhodiola rosea P.E. are Layn, Huisong Pharmaceuticals, Jinrui Natural Ingredients, Skyherb, Martin Bauer Group, etc. The top four companies occupied 27% of the total amount.
China is the dominate producer and exporter of rhodiola rosea P.E., with the production market share of 74%.
This report aims to provide a comprehensive presentation of the global market for Rhodiola Rosea P.E., with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rhodiola Rosea P.E..
Report Scope
The Rhodiola Rosea P.E. market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Rhodiola Rosea P.E. market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rhodiola Rosea P.E. manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-34U400/Global_Rhodiola_Rosea_P_E_Market_Insights_and_Forecast_to_2028

Segment by Type
• Rosavin
• Salidroside
Segment by Application
• Cosmetics
• Health Care Products
• Pharmaceuticals
• Others

By Company
Layn, Martin Bauer Group, Skyherb, Acetar Bio-Tech, Shaanxi Jintai, Gansu Xinhuikang, Bioland, Jinrui Natural Ingredients, Anhui Kunda Biological, Wagott, Huisong Pharmaceuticals, Xi'an GreenMan, Yuensun Biological Technology, Xi'an Hao Tian, Xi'an Gaoyuan

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-34U400/global-rhodiola-rosea-p-e

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.